IFU
ABBV icon

iSAM Funds (UK)’s AbbVie ABBV Stock Holding History

iSAM Funds (UK)’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,442
Closed -$797K – 299
2025
Q3 		$797K Sell
3,442
-14,825
-81% -$3.02M 0.16% 191
2025
Q2 		$3.39M Buy
+18,267
New +$3.39M 0.74% 16
2023
Q3 		– Sell
-5,413
Closed -$729K – 223
2023
Q2 		$729K Buy
5,413
+3,732
+222% +$547K 0.65% 50
2023
Q1 		$268K Buy
+1,681
New +$257K 0.34% 120

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

iSAM Funds (UK)'s ABBV Position: Q4 2025 in Review

iSAM Funds (UK) sold out of AbbVie (ABBV) in Q4 2025, closing a stake of 3,442 shares — an estimated $797K sold.

iSAM Funds (UK) first reported a position in ABBV in Q1 2023 and held it in 4 quarters. The position peaked at $3.39M in Q2 2025. 4,156 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

  • iSAM Funds (UK) reported no remaining AbbVie position as of Q4 2025 after selling out during the quarter.
  • iSAM Funds (UK) sold 3,442 AbbVie shares in Q4 2025, an estimated $797K.
  • iSAM Funds (UK) first reported a position in AbbVie in Q1 2023 and held it in 4 quarters.
  • iSAM Funds (UK)'s AbbVie position peaked at $3.39M in Q2 2025.
  • 4,156 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on iSAM Funds (UK)'s 13F filing for Q4 2025, filed 17 Feb 2026.